Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial. [electronic resource]
Producer: 20171128Description: 1538-1545 p. digitalISSN:- 2374-2445
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- adverse effects
- Asian People -- genetics
- Capecitabine -- adverse effects
- Chi-Square Distribution
- Dihydrouracil Dehydrogenase (NADP) -- genetics
- Double-Blind Method
- Drug Administration Schedule
- Female
- Folic Acid -- blood
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Hand-Foot Syndrome -- blood
- Humans
- Incidence
- Intracellular Signaling Peptides and Proteins -- genetics
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Membrane Proteins -- genetics
- Microfilament Proteins -- genetics
- Middle Aged
- Multivariate Analysis
- Neoplasms -- blood
- Odds Ratio
- Pharmacogenomic Variants
- Polymorphism, Single Nucleotide
- Predictive Value of Tests
- Pyridoxine -- administration & dosage
- Risk Assessment
- Risk Factors
- Severity of Illness Index
- Singapore -- epidemiology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.